Frequency and determinants of potential drug-drug interactions in an elderly population receiving regular home visits by GPs - Results of the home medication review in the AGnES-studies

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 12, 2011, Pages 1311-1318

  Hoffmann, Wolfgang ^a   van den Berg, Neeltje ^a   Thyrian, Jochen René ^a,b   Fiss, Thomas ^a,b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Drug related problems; Drug drug interaction; Health services research; Home medication review

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ATENOLOL; BISOPROLOL; CANDESARTAN; CAPTOPRIL; CARVEDILOL; ENALAPRIL; FORMOTEROL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IBUPROFEN; INDOMETACIN; INSULIN; LISINOPRIL; LOSARTAN; METOPROLOL; NAPROXEN; OLMESARTAN; OPIPRAMOL; PHENPROCOUMON; PROPRANOLOL; RAMIPRIL; SALBUTAMOL; SOTALOL; THEOPHYLLINE; TIMOLOL; TORASEMIDE;

AGED; AMBULATORY CARE; ARTICLE; BONE DISEASE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; PROFESSIONAL PRACTICE;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; DRUG INTERACTIONS; FEMALE; GENERAL PRACTICE; HOME CARE SERVICES; HOUSE CALLS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 81955167910     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2224     Document Type: Article

References (32)

1. Grandt D. [Improving medication safety.]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009; 52: 1161-5.
2. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 13: 1652-8.
3. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 9: 1331-6.
4. Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf 2006; 16: 641-51.
5. Hämmerlein A, Griese N, Schulz M. Survey of drug-related problems identified by community pharmacies. Ann Pharmacother 2007; 11: 1825-32.
6. Hazlet TK, Lee TA, Hansten PD, Horn JR. Performance of community pharmacy drug interaction software. J Am Pharm Assoc (Wash) 2001; 200-5.
7. Blix HS, Viktil KK, Moger TA, Reikvam A. Identification of drug interactions in hospitals--computerized screening vs. bedside recording. J Clin Pharm Ther 2008; 2: 131-9.
8. Vonbach P, Dubied A, Krahenbuhl S, Beer JH. Evaluation of frequently used drug interaction screening programs. Pharm World Sci 2008; 4: 367-74.
9. Terschüren C, Fendrich K, van den Berg N, Hoffmann W. Implementing telemonitoring in the daily routine of a GP practice in a rural setting in northern Germany. J Telemed Telecare 2007; 4: 197-201.
10. van den Berg N, Kleinke S, Heymann R, Oppermann RF, Jakobi B, Hoffmann W. Transfer of the AGnES Concept to the Regular German Health-Care System: Legal Evaluation, Reimbursement, Qualification. Gesundheitswesen 2009; 75: 285-92.
11. van den Berg N, Meinke C, Heymann R, Fiss T, Suckert E, Pöller C, et al. AGnES: Hausarztunterstützung durch qualifizierte Praxismitarbeiter [AGnES: Supporting General Practitioners with qualified medical practice personnel]. Dtsch Arztebl Int 2009; 1-2: 3-9.
12. Dreier A, Rogalski H, Oppermann RF, Terschueren C, van den Berg N, Hoffmann W. A curriculum for nurses in Germany undertaking medically-delegated tasks in primary care. J Adv Nurs 2010; 3: 635-44.
13. AOK Research Insitute (WIDO). German Drug Index. [2008]. 2008. Ref Type: Data File.
14. Mühlberger N, Behrend C, Stark R, Holle R. Datenbankgestützte Online-Erfassung von Arzneimitteln im Rahmen gesundheitswissenschaftlicher Studien, Erfahrungen mit der IDOM-Software. Informatik, Biometrie und Epidemiologie in Medizin und Biologie 2003; 4: 601-11.
15. Fiss T, Ritter CA, Alte D, van den Berg N, Hoffmann W. Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany. Pharm World Sci 2010; 5: 566-76.
16. Fiss T, Ritter C, Hoffmann W. Neues Konzept zur ambulanten pharmazeutischen Betreuung [New concept for ambulatory pharmacetical care]. Dtsch Apoth Ztg 2007; 24: 2771-2.
17. Fiss T, Hoffmann W, Ritter C. Schwester AGnES auf Hausbesuch - Pharmazeutische Betreuung [Nurse AGnES on home visit - Pharmacetical Care]. Pharmazeutische Zeitung 2007; 37: 32-3.
18. Zagermann-Muncke P. ABDA-Datenbank: Welche Interaktionen werden aufgenommen? Pharm Ztg 2003 January148Available from: URL: .
19. Zagermann-Muncke P. ABDA-Datenbank als Wegweiser im Wechselwirkungsdschungel [The ABDA-database]. Pharm Ztg 2009; 1: 26-8.
20. Verordnung über die Verschreibungspflicht von Arzneimitteln (Arzneimittelverschreibungsverordnung - AMVV). Bundesministerium der Justiz 2009 [cited 2009 Jan 1];Anlage 1 zu §1 Nr. 1 und §5Available from: URL: .
21. Grobe TG, Dörning H, Schwartz FW. Inanspruchnahme nach Alter und Geschlecht. In: Barmer GEK, editor. Barmer GEK Arztreport.Schwäbisch Gmünd: ISEG Institut für Sozialmedizin, Epidemiologie und Gesundheitstechnologieforschung; 2010. p. 59-63.
22. Coca V, Nink K. Arzneimittelverordnungen nach Alter und Geschlecht. In: Schwabe U, Pfaffrath D, editors. Arzneiverordnungs-Report 2009 - Aktuelle Daten, Kosten, Trends und Kommentare.Heidelberg: Springer; 2010. p. 901-14.
23. Rothgang H, Iwansky S, Müller R, Sauer S, Unger R. The prevalence of need of care in the federal states. In: Barmer GEK, editor. Band 5, Barmer GEK Pflegereport 2010. Schriftenreihe zur Gesundheitsanalyse ed. Schwäbisch Gmünd: Asgard-Verlag; 2010. p. 47-51.
24. Reimche L, Forster AJ, van Walraven C. Incidence and contributors to potential drug-drug interactions in hospitalized patients. J Clin Pharmacol 2011; 51: 1043-50.
25. Becker ML, Kallewaard M, Caspers PW, Schalekamp T, Stricker BH. Potential determinants of drug-drug interaction associated dispensing in community pharmacies. Drug Saf 2005; 28: 371-8.
26. Moura CS, Acurcio FA, Belo NO. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci 2009; 3: 266-72.
27. Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 4: 285-91.
28. Recalde JM, Zunzunegui MV, Beland F. [Interaction of prescribed drugs in a population over 65years of age]. Aten Primaria 1998; 22: 434-9.
29. Hansten PD, Horn JR, Hazlet TK. ORCA: OpeRational ClassificAtion of drug interactions. J Am Pharm Assoc (Wash) 2001; 2: 161-5.
30. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 2003; 3: 153-8.
31. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600, 000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 2007; 10: 911-8.
32. Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996; 8: 1177-84.